Paysign, Inc. reports developments in patient affordability programs, donor compensation solutions, engagement and management platforms, and integrated payment processing for the life sciences industries. The company operates at the intersection of fintech and healthcare, serving plasma, pharmaceutical and life sciences customers with payment and program-management technologies.
Recurring updates cover earnings results, patient affordability growth, pharmaceutical copay program performance, claims-processing activity, plasma donor compensation revenue, and SaaS engagement technologies for donor and program management. Company announcements also discuss Dynamic Business Rules for mitigating copay accumulators and maximizers, physical, virtual, mobile and bank-based payment capabilities, reporting and analytics, and investor conference participation.
Paysign, a leader in prepaid card programs and digital banking services, announced its participation in the Sidoti Small-Cap Virtual Investor Conference on June 12-13, 2024.
Chief Financial Officer Jeff Baker will be available for one-on-one and small group meetings with investors during the event.
Paysign, Inc. reported strong financial results for the first quarter of 2024. With total revenues up by 30% and adjusted EBITDA growing by 135%, the company demonstrated robust growth. The patient affordability business saw a significant 305% revenue increase, contributing to overall growth. The company remains optimistic about future growth prospects and is focused on sustainable revenue and earnings growth.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.